Pediatric patients treated for sickle cell disease through the Pediatric Bone Marrow Transplantation and Cellular Therapies Program at Rutgers Cancer Institute and The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital gathered with their families and care teams to celebrate a milestone once out of reach for many people living with the disease: more than one year since completing potentially curative treatment, w…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.